Clinical Trials Browser

Not yet recruiting × Observation × Other hematologic neoplasm × Clear all

NCT06084923 2024-04-10

Outcomes of Unfit Patients With CLL Included in the GIMEMA LLC1114 Trial Who Discontinued Ibrutinib Due to Reasons Other Than Disease Progression

Not yet recruiting

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell